Pharvaris (PHVS) Tax Provisions (2021 - 2026)
Pharvaris (PHVS) posted Tax Provisions of -$319738.8 for Q1 2026, up 83.49% on a QoQ basis from -$1.9 million in Q4 2025, and little changed year-over-year from -$321118.8 in Q1 2025.
Pharvaris (PHVS) Tax Provisions (2021 - 2026) Analysis & Trends
Pharvaris' Tax Provisions history runs 6 years deep, the most recent figure standing at -$319738.8 for Q1 2026.
- Quarterly Tax Provisions changed 0.43% year-over-year to -$319738.8 in Q1 2026, while the trailing twelve-month figure through Mar 2026 was -$2.3 million (down 15.36% YoY) and the FY2025 annual result came in at -$2.2 million, down 13.7% from the prior year.
- Tax Provisions was -$319738.8 for Q1 2026 at Pharvaris, up from -$1.9 million in the prior quarter.
- Across five years, Tax Provisions topped out at $2.4 million in Q3 2022 and bottomed at -$2.9 million in Q2 2022.
- A 5-year average of -$170454.8 and a median of -$159231.4 in 2023 frame the typical range for Tax Provisions.
- Peak annual rise in Tax Provisions reached 3114.12% in 2022, while the deepest fall reached 81815.03% in 2022.
- Pharvaris' Tax Provisions stood at $1.1 million in 2022, then soared by 34.94% to $1.5 million in 2023, then sank by 191.17% to -$1.3 million in 2024, then plunged by 46.27% to -$1.9 million in 2025, then soared by 83.49% to -$319738.8 in 2026.
- Business Quant data shows PHVS's Tax Provisions at -$319738.8 in Q1 2026, -$1.9 million in Q4 2025, and $212147.3 in Q3 2025.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Taxes (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - | 125,146.46 |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | -859,000.00 |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn | 31.86 Mn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn | 221.50 Mn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn | 104.00 Mn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn | -60.00 Mn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - | - |
| 10 | Pharvaris | 2.22 Bn | 1.94 Bn | - | -319,738.83 |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -319,738.83 |
| Dec 31, 2025 | -1.94 Mn |
| Sep 30, 2025 | 212,147.26 |
| Jun 30, 2025 | -229,541.05 |
| Mar 31, 2025 | -318,370.71 |
| Dec 31, 2024 | -1.32 Mn |
| Sep 30, 2024 | -252,690.42 |
| Jun 30, 2024 | -76,053.03 |
| Mar 31, 2024 | -309,740.21 |
| Dec 31, 2023 | 1.45 Mn |
| Sep 30, 2023 | -159,231.39 |
| Jun 30, 2023 | -102,552.72 |
| Mar 31, 2023 | -65,105.69 |
| Dec 31, 2022 | 1.08 Mn |
| Sep 30, 2022 | 2.42 Mn |
| Jun 30, 2022 | -2.92 Mn |
| Mar 31, 2022 | -43,451.30 |
| Dec 31, 2021 | 102.66 Bn |
| Sep 30, 2021 | -80,415.60 |
| Jun 30, 2021 | -3,570.66 |